Literature DB >> 15162345

Association between quantitative sensory testing, treatment choice, and subsequent pain reduction in vulvar vestibulitis syndrome.

Michal Granot1, Etan Z Zimmer, Michael Friedman, Lior Lowenstein, David Yarnitsky.   

Abstract

UNLABELLED: The chronic pain syndrome of vulvar vestibulitis is a major cause of sexual dysfunction, and complete cure is not always achieved. The aim of the study was to determine whether the psychophysical characteristics of systemic pain perception predict treatment choice and outcome. Ninety women with vulvar vestibulitis syndrome were evaluated by using quantitative sensory testing with heat pain threshold measurements and pain scores for suprathreshold stimuli applied to the forearm, blood pressure measurements, and an assessment of the number of other pain disorders. Women were free to choose a surgical procedure (ie, vestibulectomy), one of the possible nonsurgical treatments (eg, biofeedback, cognitive-behavioral therapy, or hypoallergic agents), or to avoid treatment entirely. Eight months later, women reported the success of the treatment on the basis of reduction in the level of vulvar pain. Vestibulectomy demonstrated the best therapeutic effectiveness (chi2, 26.4; P <.0001). Women who chose this type of treatment had lower pain scores (P =.038) and fewer pain syndromes other than the vulvar pain (P =.025). Logistic regression analysis, controlling for the effect of vestibulectomy, indicated that lower experimental pain scores (P =.044), fewer pain disorders (P =.023), and higher systolic blood pressure (P =.039) are predictive variables for reduction of vulvar pain. An assessment of systemic pain perception might be helpful in choosing the optimal treatment and in predicting its success. PERSPECTIVE: The present study suggests that pain perception variables might be of value in the prediction of treatment choice and outcome among women with vulvar vestibulitis. Copyright 2004 American Pain Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162345     DOI: 10.1016/j.jpain.2004.03.005

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  18 in total

Review 1.  Individual differences in pain responses.

Authors:  Roger B Fillingim
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

2.  Self-reported pain sensitivity: lack of correlation with pain threshold and tolerance.

Authors:  Robert R Edwards; Roger B Fillingim
Journal:  Eur J Pain       Date:  2006-11-22       Impact factor: 3.931

3.  Natural history of comorbid orofacial pain among women with vestibulodynia.

Authors:  Eric Bair; Elizabeth Simmons; Jessica Hartung; Kinnari Desia; William Maixner; Denniz Zolnoun
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

4.  Elevated pain sensitivity in chronic pain patients at risk for opioid misuse.

Authors:  Robert R Edwards; Ajay D Wasan; Ed Michna; Seth Greenbaum; Ed Ross; Robert N Jamison
Journal:  J Pain       Date:  2011-06-16       Impact factor: 5.820

Review 5.  Psychological screening/phenotyping as predictors for spinal cord stimulation.

Authors:  Claudia M Campbell; Robert N Jamison; Robert R Edwards
Journal:  Curr Pain Headache Rep       Date:  2013-01

6.  Overlap between orofacial pain and vulvar vestibulitis syndrome.

Authors:  Denniz A Zolnoun; Jacqueline Rohl; Charity G Moore; Cara Perinetti-Liebert; Georgine M Lamvu; William Maixner
Journal:  Clin J Pain       Date:  2008 Mar-Apr       Impact factor: 3.442

7.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

8.  Alteration in pain modulation in women with persistent pain after lumpectomy: influence of catastrophizing.

Authors:  Robert R Edwards; George Mensing; Christine Cahalan; Seth Greenbaum; Sanjeet Narang; Inna Belfer; Kristin L Schreiber; Claudia Campbell; Ajay D Wasan; Robert N Jamison
Journal:  J Pain Symptom Manage       Date:  2012-10-25       Impact factor: 3.612

9.  Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response.

Authors:  Candace S Brown; David C Foster; Jim Y Wan; Leslie A Rawlinson; Gloria A Bachmann
Journal:  Contemp Clin Trials       Date:  2013-06-29       Impact factor: 2.226

10.  Somatization and psychological distress among women with vulvar vestibulitis syndrome.

Authors:  Denniz Zolnoun; Eliza M Park; Charity G Moore; Cara A Liebert; Frank F Tu; Sawson As-Sanie
Journal:  Int J Gynaecol Obstet       Date:  2008-07-16       Impact factor: 3.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.